Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation Plan

v3.8.0.1
Stock-Based Compensation Plan
9 Months Ended
Sep. 30, 2017
Stock-Based Compensation Plan [Abstract]  
Stock-Based Compensation Plan

NOTE 12.  STOCK-BASED COMPENSATION PLAN



Under the Company’s current 2015 Stock Incentive Plan (the “2015 Plan”), the Company’s Board of Directors (the “Board of Directors”) has flexibility to determine the type and amount of awards to be granted to eligible participants, who must be employees, directors, officers or consultants of the Company or its subsidiaries.  The 2015 Plan allows for grants of incentive stock options, nonqualified stock options, restricted stock awards, stock appreciation rights, and restricted units.  The aggregate number of shares of common stock that may be granted through awards under the 2015 Plan to any employee in any calendar year may not exceed 500 shares.  The 2015 Plan will continue in effect until December 2025 unless terminated sooner. 



During the nine months ended September 30, 2017, the Company issued stock options for an aggregate of 463 shares under the 2015 Plan to directors and employees of the Company.  Of the 463 options issued, 38 options vest in four equal consecutive quarterly tranches from the date of grant.  325 vest in three equal tranches on December 31, 2017, December 31, 2018 and December 31, 2019.  The remaining 100 options vested immediately.



For computing the fair value of the stock-based awards, the fair value of each option grant has been estimated as of the date of grant using the Black-Scholes option-pricing model with the following assumptions:







 

 

 

 

Options Granted During the Nine Months Ended September 30, 2017

 

 

 

 



 

 

 

 

Number of options

 

363

 

100

Option vesting period

 

1-2 Years

 

Immediate

Grant price

 

$6.10 - $6.15

 

$6.10

Dividend yield

 

0.00%

 

0.00%

Expected volatility (a)

 

41.9% - 42.2%

 

46.90%

Risk-free interest rate

 

1.80%

 

1.41%

Expected life (years) (b)

 

5.31 - 5.33

 

2.75

Weighted average fair value

 

$2.45 - $2.49

 

$1.20



 

 

 

 

(a)

Expected volatility is based upon the Company’s historical volatility.



(b)

Because the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term for these grants, the Company utilized the simplified method in developing an estimate of the expected term of these options.



On June 1, 2017, the Company issued and granted to an employee a restricted stock award of 500 restricted shares under the 2015 Plan, of which (i) 250 restricted shares will vest if, on or before June 1, 2022, the Fair Market Value (as defined in the Plan) of the Company’s common stock shall have equaled or exceeded $10.00 per share for twenty consecutive trading days; and (ii) 250 restricted shares will vest if, on or before June 1, 2022, the Fair Market Value (as defined in the Plan) of the Company’s common stock shall have equaled or exceeded $12.00 per share for twenty consecutive trading days.  For computing the fair value of the 500 restricted shares with a market condition, the fair value of each restricted stock award grant has been estimated as of the date of grant using the Monte-Carlo pricing model with the assumptions below.

















Market Condition Restricted Shares Granted on June 1, 2017







 

 

 

 

Number issued

 

250

 

250

Vesting period

 

$10.00 stock price target

 

$12.00 stock price target

Grant price

 

$6.10

 

$6.10

Dividend yield

 

0.0%

 

0.0%

Expected volatility

 

42.4%

 

42.4%

Risk-free interest rate

 

1.76%

 

1.76%

Weighted average fair value

 

$4.30

 

$3.68



The total non-cash stock compensation expense related to restricted stock, stock options and stock awards recorded by the Company for the three months ended September 30, 2017 and 2016 was $387 and $42, respectively, and for the nine months ended September 30, 2017 and 2016 was $729 and $193, respectively.  For the three and nine months ended September 30, 2017 and 2016, the majority of stock-based compensation costs were classified as selling, general and administrative expense.  The fair value of unvested restricted stock awards is determined based on the market price of our shares of common stock on the grant date or using the Monte-Carlo pricing model. 



As of September 30, 2017, there were 533 unvested stock options and unrecognized compensation cost of $1,153 related to unvested stock options, as well as 850 unvested restricted stock awards and unrecognized compensation cost of $1,679 related to unvested restricted stock awards.